Latest News
Last week's inflation report all but ensured interest rates will be nudged higher again on Wednesday of this week.
Via The Motley Fool · September 14, 2026
CVS Health is looking more attractive -- and it sports an appealing dividend, too, recently yielding 2.8%.
Via The Motley Fool · September 14, 2026
XRP and Solana altcoin ETFs like XRPI and BSOL are drawing strong institutional inflows amid rebounding prices, though both tokens remain down significantly year to date.
Via MarketBeat · September 14, 2026
What goes down fast can go back up just as quickly when sentiment recovers.
Via The Motley Fool · September 14, 2026
The retailer is scheduled to release its fourth-quarter earnings later this month.
Via The Motley Fool · September 14, 2026
You might have more options than you think.
Via The Motley Fool · September 14, 2026
If we're still in the early stages of AI, then Bloom could have years of growth ahead.
Via The Motley Fool · September 14, 2026
The communications platform provider reported a notable insider sale on the heels of the stock hitting a 52-week high.
Via The Motley Fool · September 14, 2026
Nvidia fell, Microsoft rose, and both moves trace back to the same weekend essay. Meanwhile, oil prices are soaring again.
Via The Motley Fool · September 14, 2026
Target, Hormel and Procter & Gamble, all Dividend Kings, are rebounding from depressed valuations with reliable yields, improving traffic or market share trends, and firming analyst support.
Via MarketBeat · September 14, 2026
As AI spending strains free cash flow, Alphabet and Meta have halted share buybacks and share counts are rising, while Microsoft holds steady and NVIDIA posts record repurchases.
Via MarketBeat · September 14, 2026
The 10-year Treasury yield touched 5% for the first time since October 2023. Will the stock market tank if the Fed raises interest rates?
Via Investor's Business Daily · September 14, 2026
These S&P500 stocks are the most active in today's sessionchartmill.com
Via Chartmill · September 14, 2026
Johnson & Johnson (NYSE:JNJ) executives said the company remains on track to grow through biosimilar competition for STELARA and expects its portfolio of medicines, medical devices and pipeline programs to support accelerating growth through the end of the decade.
Speaking at a Morgan Stanley e
Via MarketBeat · September 14, 2026
Calls for a slowdown in AI development sent the cybersecurity specialist higher.
Via The Motley Fool · September 14, 2026
Most active stocks in Monday's sessionchartmill.com
Via Chartmill · September 14, 2026
The stock's high valuation will likely put expectations incredibly high for the Duo.
Via The Motley Fool · September 14, 2026
This coming January's cost-of-living adjustment is already two-thirds determined, with a pretty good idea of what that last one-third will be.
Via The Motley Fool · September 14, 2026
Industry leaders rattle AI stocks as they speak out about rapid development and call for a slower pace of growth, today, Sept. 14, 2026.
Via The Motley Fool · September 14, 2026
What Happened? A number of stocks jumped in the afternoon session after shares of enterprise software and SaaS companies rallied broadly as investors rotated...
Via StockStory · September 14, 2026
What Happened? A number of stocks jumped in the afternoon session after shares of enterprise software and SaaS companies rallied broadly as investors rotated...
Via StockStory · September 14, 2026
What Happened? A number of stocks jumped in the afternoon session after shares of enterprise software and SaaS companies rallied broadly as investors rotated...
Via StockStory · September 14, 2026
What Happened? A number of stocks jumped in the afternoon session after shares of enterprise software and SaaS companies rallied broadly as investors rotated...
Via StockStory · September 14, 2026
What Happened? A number of stocks jumped in the afternoon session after shares of enterprise software and SaaS companies rallied broadly as investors rotated...
Via StockStory · September 14, 2026
What Happened? A number of stocks jumped in the afternoon session after shares of enterprise software and SaaS companies rallied broadly as investors rotated...
Via StockStory · September 14, 2026